Clinical Trial Update: ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia [Phase 4]

View source ↗

Summary

Phase 4 multi-center trial ALL-REZ BFM 2002 for children with relapsed acute lymphoblastic leukemia has completed enrollment and status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Lymphoblastic Leukemia, Acute, Lymphoma, Non-Hodgkin | Phase 4 | Status: COMPLETED